Nutex Health Inc 2026年季度报告

or Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),and (2) has been subject to such filing requirements for the past 90 days. Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required tosubmit such files). Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smallerreporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐No☒ As of April28, 2026, the registrant had 6,881,339 shares of common stock, $0.001 par value, outstanding. Includes the additionalshares issuable to satisfy existing earn out obligations. NUTEX HEALTH INC.FORM 10-QTABLE OF CONTENTS Item 1.Financial Statements4Condensed Consolidated Balance Sheets (unaudited)4Condensed Consolidated Statements of Operations (unaudited)5Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited)6Condensed Consolidated Statements of Cash Flows (unaudited)7Notes to Condensed Consolidated Financial Statements (unaudited)8Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations24Item 3.Quantitative and Qualitative Disclosures About Market Risk36Item 4.Controls and Procedures36 INTRODUCTORY NOTE Unless the context dictates otherwise, references in this Quarterly Report on Form 10-Q to the “Company,” “we,” “us,” “our,” “Nutex”and similar words are references to Nutex Health Inc., a Delaware corporation, and its consolidated subsidiaries and affiliated entities,as appropriate, including its consolidated variable interest entities (“VIEs”). CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This Quarterly Report contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, asamended (the “Securities Act”), and Section 21E of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”). Weintend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in thePrivate Securities Litigation Reform Act of 1995 and include this statement for purposes of complying with these safe harborprovisions. This document contains certain forward-looking statements with respect to our financial condition, results of operations and business,plans, objectives and strategies. These forward-looking statements can be identified by the fact that they do not relate only to historicalor current facts. Forward-looking statements often use words such as “estimate,” “project,” “predict,” “will,” “would,” “should,”“could,” “may,” “might,” “anticipate,” “plan,” “intend,” “believe,” “expect,” “aim,” “goal,” “target,” “objective,” “commit,”“advance,” “likely” or similar expressions that convey the prospective nature of events or outcomes. These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions andassessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operatingenvironments, future developments and other factors we believe appropriate. By their nature, forward-looking statements involveknown and unknown risks and uncertainties because they relate to events and depend on circumstances that will occur in the future.The factors described in the context of such forward-looking statements in this document could cause our plans, actual results,performance or achievements, industry results and developments to differ materially from those expressed in or implied by suchforward-looking statements. Although we believe that the expectations reflected in such forward-looking statements are reasonable, wecannot assure you that such expectations will prove to have been correct and persons reading this document are therefore cautioned notto place undue reliance on these forward-looking statements, which speak only as of the date of this Quarterly Report. We do notassume any obligation to update the information contained in this document (whether as a result of new information, f